Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

691 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Single-agent epirubicin as primary chemotherapy in T2-T3, N0-N2, M0 breast carcinoma: 6-year follow-up.
Barni S, Piazza E, Frontini L, Visini M, Ardizzoia A, Grassi MM, Nosenzo MA, Mandalà M, Biasioli R, Freddi E, Lucani L, Recalcati A, Pravettoni A, Sala R, Rezzani C, Villa S, Trabucchi E; Neo-Adjuvant Breast Italian Group. Barni S, et al. Among authors: villa s. Oncology. 2004;67(1):40-7. doi: 10.1159/000080284. Oncology. 2004. PMID: 15459494 Clinical Trial.
5-year results of cisplatin-epirubicin-vinorelbine (PEV) combination as primary chemotherapy in T2-3, N0-2 breast cancer patients: a multicentre phase II study.
Barni S, Visini M, Piazza E, Ionta MT, Ardizzoia A, Arnoldi E, Fava S, Pinotti G, Torretta F, Corradini G, Villa S, Nosenzo AM, Massidda B, Cazzaniga ME. Barni S, et al. Among authors: villa s. Anticancer Res. 2007 Jul-Aug;27(4C):3019-24. Anticancer Res. 2007. PMID: 17695490 Free article. Clinical Trial.
Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations.
Cerea G, Vaghi M, Ardizzoia A, Villa S, Bucovec R, Mengo S, Gardani G, Tancini G, Lissoni P. Cerea G, et al. Among authors: villa s. Anticancer Res. 2003 Mar-Apr;23(2C):1951-4. Anticancer Res. 2003. PMID: 12820485 Clinical Trial.
691 results